Intracerebral Production of Tumor Necrosis Factor-α, a Local Neuroprotective Agent, in Alzheimer Disease and Vascular Dementia

Cited by (348)

Items 101–200 of 348

1. Targeting Synaptic Dysfunction in Alzheimer’s Disease Therapy
   Robert Nisticò, Marco Pignatelli, Sonia Piccinin, Nicola Biagio Mercuri, Graham L. Collingridge · 2012 · Molecular Neurobiology
2. The radical scavenger edaravone prevents oxidative neurotoxicity induced by peroxynitrite and activated microglia
   Masahiro Banno, Tetsuya Mizuno, Hideki Kato, Guiqin Zhang, Jun Kawanokuchi, Jinyan Wang, Reiko Kuno, Shijie Jin, Hideyuki Takeuchi, Akio Suzumura · 2004 · Neuropharmacology
3. Periodontitis, Microbiomes and their Role in Alzheimer’s Disease
   Anna Barlach Pritchard, StJohn Crean, Ingar Olsen, Sim K. Singhrao · 2017 · Frontiers in Aging Neuroscience
4. Changes in the cellular distribution of glutamine synthetase in Alzheimer's disease
   Stephen R. Robinson · 2001 · Journal of Neuroscience Research
5. Systemic Inflammation and the Risk of Alzheimer's Disease and Dementia: A Prospective Population-Based Study
   Johan E. Sundelöf, Lena Kilander, Johanna Helmersson, Anders Olof Larsson, Elina Rönnemaa, Malin Degerman-Gunnarsson, Hans Basun, Lars Lannfelt, Samar Basu · 2009 · Journal of Alzheimer s Disease
6. Interleukin 6 and cognitive dysfunction
   Isabel Trapero, Omar Cauli · 2014 · Metabolic Brain Disease
7. Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration
   Daniela Galimberti, Eliana Venturelli, Chiara Fenoglio, Ilaria Guidi, Chiara Villa, Luigi Cesare Bergamaschini, Francesca Cortini, Diego Scalabrini, Pierluigi Baron, Carlo Vergani et al. · 2008 · Journal of Neurology
8. Lipid metabolism and neuroinflammation in Alzheimer’s disease: a role for liver X receptors
   Kang, Jihong, Rivest, Serge · 2012 · Endocrine Reviews
9. Early intervention with a small molecule inhibitor for tumor nefosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer’s disease
   S. Prasad Gabbita, Minu K. Srivastava, Pirooz Eslami, Ming F. Johnson, Naomi Kobritz, David Tweedie, Nigel H. Greig, Frank P. Zemlan, Sherven P. Sharma, Marni E. Harris‐White · 2012 · Journal of Neuroinflammation
10. Decline of immune responsiveness: A pathogenetic factor in Alzheimer’s disease?
    E. Richartz, Elke Stransky, Anil Batra, Perikles D. Simon, Piotr Lewczuk, Gerhard Buchkremer, M BARTELS, Klaus J. Schott · 2005 · Journal of Psychiatric Research
11. Novel Disease-Modifying Therapies for Alzheimer's Disease
    Teng Jiang, Jin‐Tai Yu, Lan Tan · 2012 · Journal of Alzheimer s Disease
12. Gender-Specific Neuroimmunoendocrine Aging in a Triple-Transgenic 3×Tg-AD Mouse Model for Alzheimer’s Disease and Its Relation with Longevity
    Giménez-Llort, Lydia, Arranz, Lorena, Maté, Ianire, De la Fuente, Mónica · 2008 · Neuroimmunomodulation
13. Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer’s disease
    Julius Popp, Michael Bacher, Heike Kölsch, Carmen Noelker, Oliver Deuster, Richard C. Dodel, Frank Jessen · 2008 · Journal of Psychiatric Research
14. Serum tumour necrosis factor‐α and interleukin‐6 levels in Alzheimer's disease and mild cognitive impairment
    Yo Sup Kim, Kang Joon Lee, Hyun Kim · 2017 · Psychogeriatrics
15. Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report
    Anders Wallin, Elisabeth Kapaki, Marina Boban, Sebastian Engelborghs, Dirk Matthias Hermann, Branko N. Huisa, Michael A. G. Jonsson, Milica Gregorič Kramberger, Laura Lossi, Branko Malojčić et al. · 2017 · BMC Neurology
16. Cyclin' toward dementia
    Arun K. Raina, Xiongwei Zhu, Catherine A. Rottkamp, Mervyn J. Monteiro, Atsushi Takeda, Mark A. Smith · 2000 · Journal of Neuroscience Research
17. Defining the Microglia Response during the Time Course of Chronic Neurodegeneration
    Vincenti, James E., Murphy, Lita, Grabert, Kathleen, McColl, Barry W., Cancellotti, Enrico, Freeman, Tom C., Manson, Jean C. · 2016 · Journal of Virology
18. The Potential Role of Chemokines in Alzheimer’s Disease Pathogenesis
    Gholamreza Azizi, Nikoo Hossein‐Khannazer, Abbas Mirshafiey · 2014 · American Journal of Alzheimer s Disease & Other Dementias®
19. Biomarkers for Alzheimer’s Disease
    Guzman-Martinez, Leonardo, Maccioni, Ricardo B., Farías, Gonzalo A., Fuentes, Patricio, Navarrete, Leonardo P. · 2019 · Current Alzheimer Research
20. Friend, Foe or Both? Immune Activity in Alzheimer’s Disease
    Georgia R. Frost, Lauren A. Jonas, Yue‐Ming Li · 2019 · Frontiers in Aging Neuroscience
21. Learning performances, brain NGF distribution and NPY levels in transgenic mice expressing TNF-alpha
    Marco Fiore, Francesco Angelucci, Enrico Alleva, Igor Branchi, Lesley Probert, Luigi Aloe · 2000 · Behavioural Brain Research
22. Inflammatory markers in Alzheimer's disease and multi-infarct dementia
    Ada De Luigi, Claudia Fragiacomo, Ugo Lucca, Pierluigi Quadri, Mauro Tettamanti, Maria Grazia De Simoni · 2001 · Mechanisms of Ageing and Development
23. Resveratrol exerts anti-inflammatory and neuroprotective effects to prevent memory deficits in rats exposed to chronic unpredictable mild stress
    Yusufhan Yazır, Tijen Utkan, Nejat Gacar, Feyza Arıcıoğlu · 2014 · Physiology & Behavior
24. Omega‐3 Fatty Acid Supplementation Effects on Weight and Appetite in Patients with Alzheimer's Disease: The Omega‐3 Alzheimer's Disease Study
    Gerd Faxén Irving, Yvonne Freund‐Levi, Maria Eriksdotter, Hans Basun, Kerstin Brismar, Erik Hjorth, Jan E.W. Palmblad, Bengt OH Vessby, Inger Vedin, Lars‐Olof Wahlund et al. · 2008 · Journal of the American Geriatrics Society
25. β-Amyloid Protein Structure Determines the Nature of Cytokine Release From Rat Microglia
    Catharina Lindberg, Maj‐Linda B. Selenica, Anita Westlind‐Danielsson, Marianne Schultzberg · 2005 · Journal of Molecular Neuroscience
26. Association between the TNFα‐308 A/G polymorphism and the onset‐age of Alzheimer disease
    Victoria Álvarez, Ignacio Fernandez Mata, Pelayo González, Carlos Lahoz, Carmen Martínez, Joaquín Peña, Luis M. Guisasola, Eliécer Coto · 2002 · American Journal of Medical Genetics
27. Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease
    Md. Sahab Uddin, Md. Tanvir Kabir, Maroua Jalouli, Md. Ataur Rahman, Philippe Jeandet, Tapan Behl, Athanasios T. Alexiou, Ghadeer Mohsen Albadrani, Mohamed M. Abdel‐Daim, Asma Perveen et al. · 2021 · Current Neuropharmacology
28. Genetics of Vascular Dementia: Systematic Review and Meta-Analysis
    Jiahao Sun, Lan Tan, Hui-Fu Wang, Meng-Shan Tan, Lin Tan, Jieqiong Li, Wei Xu, Xi-Chen Zhu, Teng Jiang, Jin-Tai Yu · 2015 · Journal of Alzheimer s Disease
29. TNF-α/NF-κB Signaling in the CNS: Possible Connection to EPHB2
    Paul D. Pozniak, Martyn K. White, Kamel Khalili · 2013 · Journal of Neuroimmune Pharmacology
30. Neuroinflammatory challenges compromise neuronal function in the aging brain: Postoperative cognitive delirium and Alzheimer’s disease
    Giuseppe P. Cortese, Corinna Bürger · 2016 · Behavioural Brain Research
31. Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach
    Karin D. van Dijk, Charlotte Elisabeth Teunissen, Benjamin Drukarch, Connie R. Jiménez, Henk J. Groenewegen, Henk W. Berendse, Wilma D. J. van de Berg · 2010 · Neurobiology of Disease
32. Natural Compounds and Plant Extracts as Therapeutics Against Chronic Inflammation in Alzheimer’s Disease – A Translational Perspective
    Nadine Apetz, Gerald W Münch, Suresh Govindaraghavan, Erika Gyengési · 2014 · CNS & Neurological Disorders - Drug Targets
33. TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels
    Simon Matthew Laws, Robert Perneczky, Stefan Wagenpfeil, Ulrich Müller, Hans Förstl, Ralph Nigel Martins, Alexander Kurz, Markus J. Riemenschneider · 2005 · Human Mutation
34. Peripheral cytokine release in Alzheimer patients: correlation with disease severity
    Gessica Sala, Gloria Galimberti, Carla Canevari, Maria Elisabetta Raggi, Valeria Isella, Maurizio Facheris, Ildebrando Marco Appollonio, Carlo Ferrarese · 2003 · Neurobiology of Aging
35. Levels of Amyloid Beta-42, Interleukin-6 and Tumor Necrosis Factor-Alpha in Alzheimer’s Disease and Vascular Dementia
    Sema Uslu, Zubeyde Eken Akarkarasu, Demet Özbabalık, Serhat Özkan, Ömer Çolak, Emine Sütken Demirkan, Ayşe Özkıriş, Canan Demirüstü, Özkan Alataş · 2012 · Neurochemical Research
36. Microglial interaction with β‐amyloid: Implications for the pathogenesis of Alzheimer's disease
    Maria E. Bamberger, Gary E. Landreth · 2001 · Microscopy Research and Technique
37. Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients
    Kenji Wada‐Isoe, Yosuke Wakutani, Katsuya Urakami, Kenji Nakashima · 2004 · Acta Neurologica Scandinavica
38. Interleukin‐1β but not tumor necrosis factor‐α potentiates neuronal damage by quinolinic acid: Protection by an adenosine A2Areceptor antagonist
    Trevor W. Stone, W. M. H. Behan · 2007 · Journal of Neuroscience Research
39. Anomalously phosphorylated tau and Aβ fragments in the CSF correlates with cognitive impairment in MCI subjects
    Ricardo Benjamin Maccioni, Manuel Lavados M, Marta Guillón, Carmen Luisa Domínguez Mújica, R BOSCH, G FARIAS, P FUENTES · 2005 · Neurobiology of Aging
40. Exploring the Formation of Alzheimer's Disease Senile Plaques in Silico
    Leah Edelstein‐Keshet, Äthan Spiros · 2002 · Journal of Theoretical Biology
41. CX3CL1/CX3CR1 in Alzheimer’s Disease: A Target for Neuroprotection
    Peiqing Chen, Wenjuan Zhao, Yanjie Guo, Juan Xu, Ming Yin · 2016 · BioMed Research International
42. An internally controlled peripheral biomarker for Alzheimer’s disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin
    Tapan K. Khan, Daniel L. Alkon · 2006 · Proceedings of the National Academy of Sciences
43. Perispinal etanercept: a new therapeutic paradigm in neurology
    Edward Lewis Tobinick · 2010 · Expert Review of Neurotherapeutics
44. TACE/ADAM17–TNF-α Pathway in Rat Cortical Cultures after Exposure to Oxygen–Glucose Deprivation or Glutamate
    Olivia Hurtado, Ignacio Lizasoaín, Paz Fernández-Tomé, Alberto M. Alvarez, Juan Carlos Leza, Pedro Luis Lorenzo, María Ángeles Moro · 2002 · Journal of Cerebral Blood Flow & Metabolism
45. Innate Immune Functions of Astrocytes are Dependent Upon Tumor Necrosis Factor-Alpha
    Kyla R. Rodgers, Yufan Lin, Thomas J. Langan, Yoichiro Iwakura, Richard C. Chou · 2020 · Scientific Reports
46. Microglial—Macrophage Synthesis of Tumor Necrosis Factor after Focal Cerebral Ischemia in Mice is Strain Dependent
    Kate Lykke Lambertsen, Rikke Gregersen, Bente R. Finsen · 2002 · Journal of Cerebral Blood Flow & Metabolism
47. Normal pressure hydrocephalus triggers intrathecal production of TNF-α
    Elisabeth Tarkowski, Mats Tullberg, Pam Fredman, Carsten Wikkelsø · 2003 · Neurobiology of Aging
48. c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells
    Eva Ceballos, M. Dolores Delgado, Pilar Gutierrez, Carlos Richard, Daniel Müller, Martin Eilers, Mats Ehinger, Urban Gullberg, Javier León · 2000 · Oncogene
49. Associations Between Inflammation and Cognitive Function in African Americans and European Americans
    Beverly Gwen Windham, Brittany N. Simpson, Seth T. Lirette, John M. Bridges, Lawrence F. Bielak, Patricia A. Peyser, Iftikhar J. Kullo, Stephen T. Turner, Michael E Griswold, Thomas H. Mosley · 2014 · Journal of the American Geriatrics Society
50. Peripheral Inflammatory Response in Alzheimer's Disease and Multiinfarct Dementia
    Ada De Luigi, Simone Pizzimenti, Pierluigi Quadri, Ugo Lucca, Mauro Tettamanti, Claudia Fragiacomo, Maria Grazia De Simoni · 2002 · Neurobiology of Disease
51. Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's disease
    Christopher Lindberg, Milan Chromek, Leif Ahrengart, Annelie Brauner, Marianne Schultzberg, Anita Garlind · 2005 · Neurochemistry International
52. Lithostathine and pancreatitis-associated protein are involved in the very early stages of Alzheimer's disease
    Laure Duplan · 2001 · Neurobiology of Aging
53. Telomere Dysfunction of Lymphocytes in Patients With Alzheimer Disease
    Jianmin Zhang, Qingli Kong, Zhenxin Zhang, Pingjiang Ge, Denian Ba, Wei He · 2003 · Cognitive and Behavioral Neurology
54. Perispinal etanercept for neuroinflammatory disorders
    Edward Lewis Tobinick · 2008 · Drug Discovery Today
55. Cerebrospinal fluid cytoskeleton proteins in patients with subcortical white-matter dementia
    Anders Wallin, Magnus J.C. Sjögren · 2001 · Mechanisms of Ageing and Development
56. Interleukin-1β Drives Cellular Senescence of Rat Astrocytes Induced by Oligomerized Amyloid β Peptide and Oxidative Stress
    Dongsheng Shang, Yin Hong, Wangwang Xie, Zhigang Tu, Jun Liang Xu · 2020 · Frontiers in Neurology
57. Immunohistochemical study of the expression of cytokines and nitric oxide synthases in brains of patients with dementia with Lewy bodies
    Omi Katsuse, Eizo Iseki, Kenji Kosaka · 2003 · Neuropathology
58. Apolipoprotein J (clusterin) activates rodent microglia in vivo and in vitro
    Xie, Z., Harris‐White, M. E., Wals, P. A., Frautschy, S. A., Finch, C. E., Morgan, T. E. · 2005 · Journal of Neurochemistry
59. Effects of TNFα-Converting Enzyme Inhibition on Amyloid β Production and APP ProcessingIn VitroandIn Vivo
    Minkyu L. Kim, Bin Zhang, Ian P. Mills, Marcos E. Milla, Kurt R. Brunden, Virginia M.‐Y. Lee · 2008 · Journal of Neuroscience
60. A study on neuroinflammatory marker in brain areas of okadaic acid (ICV) induced memory impaired rats
    Pradip Kumar Kamat, Santoshkumar Tota, Shivika Rai, Supriya Swarnkar, Rakesh Shukla, Chandishwar Nath · 2012 · Life Sciences
61. TNF gene polymorphism and its relation to intracerebral production of TNFα and TNFβ in AD
    Elisabeth Tarkowski, A. Liljeroth, Anna Matilda Nilsson, Anne Ricksten, Pia Davidsson, Lennart Minthon, Kaj Blennow · 2000 · Neurology
62. Cerebrospinal Fluid Secretory Ca2+-Dependent Phospholipase A2 Activity Is Increased in Alzheimer Disease
    Sonia Chalbot, Henrik Zetterberg, Kaj Blennow, Tormod Fladby, Inge Grundke, Khalid Iqbal · 2009 · Clinical Chemistry
63. Effects of statins on microglia
    Catharina Lindberg, Milita Crisby, Bengt G. Winblad, Marianne Schultzberg · 2005 · Journal of Neuroscience Research
64. Alcohol as a Modifiable Risk Factor for Alzheimer’s Disease—Evidence from Experimental Studies
    Devaraj Venkatapura Chandrashekar, Ross A. Steinberg, Derick Han, Rachita K. Sumbria · 2023 · International Journal of Molecular Sciences
65. Neuroprotective role of tripchlorolide on inflammatory neurotoxicity induced by lipopolysaccharide-activated microglia
    Xiaodong Pan, Xiaochun Chen, Yuangui Zhu, Jing Zhang, Tianwen Huang, Limin Chen, Qin-yong Ye, Huapin Huang · 2008 · Biochemical Pharmacology
66. Pro- and anti-inflammatory cytokines in the CSF of patients with creutzfeldt-jakob disease.
    Stoeck, Katharina, Bodemer, Monika, Zerr, Inga · 2006 · Journal of Neuroimmunology
67. Molecular and cellular mediators of Alzheimer's disease inflammation
    Ron Strohmeyer, Joseph Rogers · 2001 · Journal of Alzheimer s Disease
68. Protective effects of nicergoline against neuronal cell death induced by activated microglia and astrocytes
    Tetsuya Mizuno, Reiko Kuno, Atsumi Nitta, Toshitaka Nabeshima, Guiqin Zhang, Jun Kawanokuchi, Jinyan Wang, Shijie Jin, Hideyuki Takeuchi, Akio Suzumura · 2005 · Brain Research
69. Is Adipose Tissue Inflammation the Culprit of Obesity‐Associated Comorbidities?
    Laurent Turner, Anjalee I. Wanasinghe, Pamela Brunori, Sylvia Santosa · 2025 · Obesity Reviews
70. NF-kappaB-associated MnSOD induction protects against beta-amyloid-induced neuronal apoptosis.
    Pradoldej M Sompol, Yong Xu, Wanida Ittarat, Chotiros Daosukho, Daret K. St. Clair · 2006 · PubMed
71. Novel insights into RIPK1 as a promising target for future Alzheimer’s disease treatment
    Shang Li, Lailiang Qu, Xiaobing Wang, Lingyi Kong · 2021 · Pharmacology & Therapeutics
72. Alzheimer’s disease—subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies
    Anders Wallin, Arto Nordlund, Michael A. G. Jonsson, Kaj Blennow, Henrik Zetterberg, Annika Öhrfelt, Jacob Stålhammar, Marie Eckerström, Mårten Carlsson, Erik Olsson et al. · 2015 · Journal of Cerebral Blood Flow & Metabolism
73. Microglial Activation Is Modulated by Captopril: in Vitro and in Vivo Studies
    Keren Asraf, Nofar Torika, Ron N. Apte, Sigal Fleisher‐Berkovich · 2018 · Frontiers in Cellular Neuroscience
74. Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship
    Brianne Magouirk Bettcher, Joel H. Kramer · 2012 · Neurocase
75. Serum amyloid A (SAA)-induced remodeling of CSF-HDL
    Takashi Miida, Toshiyuki Yamada, Utako Seino, Masayuki Ito, Yuriko Fueki, Akihiro Takahashi, Keiichiro Kosuge, Satoshi Soda, Osamu Hanyu, Konen Obayashi et al. · 2006 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
76. The diagnostic role of serum inflammatory and soluble proteins on dementia subtypes: Correlation with cognitive and functional decline
    Öztürk, Candan, Özge, Aynur, Yalın, Osman Özgür, Yılmaz, İ. Arda, Delialioglu, Nuran, Yıldız, Çilem, Tesdelen, Bahar, Kudiaki, Cigdem · 2007 · Behavioural Neurology
77. Cytokine production by a human microglial cell line: Effects of ßamyloid and α-melanocyte-stimulating hormone
    Catharina Lindberg, Erik Hjorth, Claes Post, Bengt G. Winblad, Marianne Schultzberg · 2005 · Neurotoxicity Research
78. Decreased Levels of Intrathecal Interleukin 1 Receptor Antagonist in Alzheimer’s Disease
    Elisabeth Tarkowski, Ann-Marie Liljeroth, Åsa Lundgren Nilsson, Lennart Minthon, Kaj Blennow · 2001 · Dementia and Geriatric Cognitive Disorders
79. Alzheimer’s Disease and Genetics of Inflammation: A Pharmacogenomic Vision
    Sonya Vasto, Giuseppina Candore, Giovanni Duro, Domenico Lio, Maria Paola Grimaldi, Calogero Caruso · 2007 · Pharmacogenomics
80. The Role of Pro-inflammatory Cytokines in Memory Processes and Neural Plasticity
    Inbal Goshen, Raz Yirmiya · 2007 · Elsevier eBooks
81. The effect of chronic periodontitis on serum levels of tumor necrosis factor-alpha in Alzheimer disease.
    Shirin Zahra Farhad, Shahram Amini, Amir Khalilian, Majid Barekatain, Morvarid Mafi, Mehrdad Barekatain, Ehsan Rafei · 2014 · Europe PMC (PubMed Central)
82. Key inflammatory pathway activations in the MCI stage of Alzheimer’s disease
    Jagan A. Pillai, Sean Maxwell, James Bena, Lynn M. Bekris, Stephen M. Rao, Mark R. Chance, Bruce T. Lamb, James B. Leverenz, Alzheimer’s Disease Neuroimaging Initiative · 2019 · Annals of Clinical and Translational Neurology
83. Piperlongumine Improves Lipopolysaccharide-Induced Amyloidogenesis by Suppressing NF-KappaB Pathway
    Sun Mi Gu, Hee Pom Lee, Young Wan Ham, Dong Ju Son, Hoi Yeong Kim, Ki Wan Oh, Sang‐Bae Han, Jaesuk Yun, Jin Tae Hong · 2018 · NeuroMolecular Medicine
84. The Tumor Necrosis Factor Alpha −308G>A Polymorphism Is Associated with Dementia in the Oldest Old
    Helle Brüünsgaard, Thomas Benfield, Karen Andersen‐Ranberg, Jacob Hjelmborg, Agnes N. Pedersen, Marianne Schroll, Bente Klarlund Pedersen, Bernard Jeune · 2004 · Journal of the American Geriatrics Society
85. Biomarkers for Alzheimer's disease
    Ernest K. J. Pauwels, Volterani, D., Marlani, G. · 2009 · Drug News & Perspectives
86. Atorvastatin prevents amyloid-β peptide oligomer-induced synaptotoxicity and memory dysfunction in rats through a p38 MAPK-dependent pathway
    Lingling Zhang, Haijuan Sui, Bing Liang, Hanming Wang, Wenhui Qu, Shengxue Yu, Ying Hua Jin · 2014 · Acta Pharmacologica Sinica
87. Declines in inflammation predict greater white matter microstructure in older adults
    Brianne Magouirk Bettcher, Kristine S. Yaffe, Robert M. Boudreau, John M Neuhaus, Howard Jay Aizenstein, Jingzhong Ding, Stephen B. Kritchevsky, Lenore J. Launer, Yongmei Liu, Suzanne Satterfield et al. · 2014 · Neurobiology of Aging
88. Protective effect of bilobalide on learning and memory impairment in rats with vascular dementia
    Weizu Li, Wangyang Wu, Huan Huang, YANG-YANG WU, Yanyan Yin · 2013 · Molecular Medicine Reports
89. Inflammation in Neurodegenerative Disorders: Friend or Foe?
    Daniela Galimberti, Chiara Fenoglio, Elio Angelo Scarpini · 2008 · Current Aging Science
90. Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence
    Tracey A. Ignatowski, Robert N. Spengler, Krishnan M. Dhandapani, Hedy Folkersma, Roger F. Butterworth, Edward Lewis Tobinick · 2014 · CNS Drugs
91. Amyloid-β reduces the expression of neuronal FAIM-L, thereby shifting the inflammatory response mediated by TNFα from neuronal protection to death
    Paulina Carriba, Sebastián Jiménez, Victoria Navarro, Inés Moreno‐González, Bruna Barneda‐Zahonero, Rana S. Moubarak, Joaquín López‐Soriano, Antonia Gutiérrez, Javier Vitórica, Joan X. Comella · 2015 · Cell Death and Disease
92. Differences in Abundances of Cell-Signalling Proteins in Blood Reveal Novel Biomarkers for Early Detection Of Clinical Alzheimer's Disease
    Mateus Rocha de Paula, Martı́n Gómez Ravetti, Regina Esther Berretta, Pablo Moscato · 2011 · PLoS ONE
93. Correlation between Intrathecal Sulfatide and TNF-α Levels in Patients with Vascular Dementia
    Elisabeth Tarkowski, Mats Tullberg, Pam Fredman, Carsten Wikkelsø · 2003 · Dementia and Geriatric Cognitive Disorders
94. The initiation of autoimmune diabetes
    E. Allison Green, Richard Anthony Flavell · 1999 · Current Opinion in Immunology
95. Early neuroinflammation is associated with lower amyloid and tau levels in cognitively normal older adults
    Albrecht, Daniel S., Sagare, Abhay, Pachicano, Maricarmen, Sweeney, Melanie D., Toga, Arthur, Zlokovic, Berislav, Chui, Helena, Joe, Elizabeth, Schneider, Lon, Morris, John C. et al. · 2021 · Brain, Behavior, and Immunity
96. Protecting the Synapse: Evidence for a Rational Strategy to Treat HIV-1 Associated Neurologic Disease
    Matthew J. Bellizzi, Shao‐Ming Lu, Harris A. Gelbard · 2006 · Journal of Neuroimmune Pharmacology
97. Systemic and Central Immunity in Alzheimer's Disease: Therapeutic Implications
    Joe Butchart, Clive Holmes · 2011 · CNS Neuroscience & Therapeutics
98. Beta-Amyloid Peptides Enhance the Proliferative Response of Activated CD4+CD28+ Lymphocytes from Alzheimer Disease Patients and from Healthy Elderly
    Agnieszka Jóźwik, Jerzy Landowski, Leszek Bidzan, Tamàs Fülöp, Ewa Bryl, Jacek Maciej Witkowski · 2012 · PLoS ONE
99. Flavonoid-rich ethanol extract from the leaves of Diospyros kaki attenuates cognitive deficits, amyloid-beta production, oxidative stress, and neuroinflammation in APP/PS1 transgenic mice
    Yingjuan Ma, Bin Ma, Yuying Shang, Qingqing Yin, Hong Yan, Song Xu, Chao Shen, Xunyao Hou, Xueping Liu · 2017 · Brain Research
100. Impact of 17β-estradiol on cytokine-mediated apoptotic effects in primary hippocampal and neocortical cell cultures
     Małgorzata Kajta, Andreas Trotter, Władysław Lasoń, Cordian Beyer · 2006 · Brain Research